University of California San Francisco
Give to UCSF
Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
Researchers devised “smart” cells that behave like tiny autonomous robots which may be used to detect damage and disease, and deliver help at just the right time and in just the right amount.
A new study from UCSF suggests that a protein found in the common bullfrog may one day be used to detect and neutralize a poisonous compound produced by red tides and other harmful algal blooms.
A two-week course of an experimental immunotherapy called teplizumab dramatically reduced type 1 diabetes (T1D) diagnosis rates in people at high risk for the disease, according to newly published
The program, supported by philanthropists Herb and Marion Sandler, funds ideas that challenge generally-accepted theories and have potentially transformative effects.
A research team led by scientists at UC San Francisco and the Chan Zuckerberg Biohub has developed a new CRISPR-based diagnostic tool, dubbed FLASH, that can rapidly identify any drug-resistant
Chuang and Keiser have shown how machine learning could lead scientists astray and how scientists might, in the future, avoid some of the pitfalls of training computers to be scientists.
UCSF researchers developed a strategy for targeting a key molecule implicated in Parkinson’s disease, opening up a potential new treatment strategy for the currently incurable movement disorder.
UCSF lab found that a chemical that acts as a neurotransmitter in the nervous system is essential for cytonemes to mediate cell-to-cell communication between non-neural cells.
More than a thousand projects across the University received federal funding from the National Institutes of Health in 2018, totaling more than $647.8 million.
Scientists at UCSF, in collaboration with colleagues at UNC, have developed the world’s largest virtual pharmacology platform and shown it is capable of identifying extremely powerful new drugs.
The first recipient of QBI's Scholarship for Women from Developing Nations in Biosciences returns to Uganda with tools for success.
The Dyad project will help address the shortage of mental health providers in California and support a team-based approach to clinical medicine.
In laboratory experiments, UCSF researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach.
Scientists identified key ways Ebola, Dengue, and Zika viruses hijack the body’s cells, and they found at least one potential drug that can disrupt this process in human cells.
A weighty new study shows that CRISPR therapies can cut fat without cutting DNA.
UCSF researchers have devised a CRISPR-based system called SLICE, which will allow scientists to rapidly assess the function of each and every gene in “primary” immune cells.
UCSF demonstrates that cancer is a clever engineer, capable of constructing entirely new disease-promoting networks out of raw materials readily available in the cell.
The Quantitative Biosciences Institute attracts investigators on the basis of the tools and techniques they employ, rather than the diseases they study.
Seven UCSF research subject areas were ranked in the top 10 globally by US News & World Report.
In new studies conducted at UCSF, a novel oxygen-delivery therapeutic restored the function of oxygen-starved heart tissue in an animal model of global hypoxia.
UCSF researchers discovered a gene that plays an essential role in noise-induced deafness.
UCSF scientists are working to understand how concussions cause long-term cognitive damage – and how they might be treated.
UCSF’s Shuvo Roy has spent the better part of a decade working on technology that could lead to a a surgically implantable bioartificial kidney. Now he is also working with UCSF colleagues to turn that technology into an artificial pancreas.
These results confirm that the HPV virus causes head and neck cancer by inactivating the same proteins that are mutated in smoking-induced cancer.
Researchers at UCSF and the Gladstone Institutes have received an $18 million grant from the National Institutes of Health to launch the Psychiatric Cell Map Initiative.
Built on a foundation of scientific thinking, and one that exposes students to the latest questions in research and patient care, the School of Pharmacy’s new curriculum differentiates UCSF’s PharmD degree program from the growing number of programs nationwide.
A collaboration between three labs at UCSF has resulted in an unprecedented look at a member of a vital and ubiquitous class of proteins called integrins.
UCSF scientists have used a high-throughput CRISPR-based technique to rapidly map the functions of nearly 500 genes in human cells, many of them never before studied in detail.
Although CRISPR has made headlines as a powerful system for editing genes, it actually evolved as way for bacteria to defend themselves against infection by viruses.
In an achievement that has significant implications for research, medicine, and industry, UCSF scientists have genetically reprogrammed human immune cells without using viruses to insert DNA
